Pacritinib: Anemia Mechanisms in MPNs -NFKB/ACVR1- [2023 SLIDES] Hematologic Malignancies 2 Mins Read12 By: Allen Wilbanks Date: September 27, 2023 Stephen Oh, MD PhD, took the podium to present his research in a…
Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 Myeloproliferative Disease 10 Mins Read2 iFrame is not supported! Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 By John Mascarenhas, MD What is the…
Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 Myeloproliferative Disease 10 Mins Read19 Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 By John Mascarenhas, MD What is the study of Pacritinib in…
